Search

iDose: An Intraocular Drug-Eluting Delivery Device for Glaucoma

Mitch Ibach, OD, FAAO

Show Description +

[No narration] Dr. Ibach demonstrates placement of the 1.8 x 0.5 mm biocompatible titanium implant iDose, which releases a proprietary formulation of travoprost inside the anterior chamber. An ab-interno approach is used to visualize the anterior chamber angle. The scleral anchor is then implanted into the trabecular meshwork, and secure attachment is ensured by nudging the device.

Posted: 6/15/2020

Keywords:

Drug Delivery

Up Next

FLACS With Toric and iStent inject

FLACS With Toric and iStent inject

Blake Williamson, MD, MPH, MS

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Targeted Placement of iStent Trabecular Micro-Bypass Stent (Glaukos)

Eric Rosenberg, MD

Cataract Surgery Combined with Canaloplasty

Cataract Surgery Combined with Canaloplasty

Mahmoud A. Khaimi, MD

Needle Viscocanalostomy

Needle Viscocanalostomy

Eslam Ramadan, MD

Ahmed M4 Placement

Ahmed M4 Placement

Nathan Radcliffe MD

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Hydrogel Sealant to Prevent Chamber Shallowing During Combined Phaco and Tube Shunt Insertion

Ian Conner, MD

Supra-Tenons Baerveldt Glaucoma Drainage Device

Supra-Tenons Baerveldt Glaucoma Drainage Device

George Tanaka, MD

iStent Trabecular Microbypass Implantation Technique

iStent Trabecular Microbypass Implantation Technique

Ike K. Ahmed MD

Trabectome 180

Trabectome 180

Constance Okeke, MD, MSCE

New Directions for GT

New Directions for GT

Arsham Sheybani, MD, Iqbal Ike K. Ahmed, MD, FRCSC

iDose: An Intraocular Drug-Eluting Delivery Device for Glaucoma

Mitch Ibach, OD, FAAO

[No narration] Dr. Ibach demonstrates placement of the 1.8 x 0.5 mm biocompatible titanium implant iDose, which releases a proprietary formulation of travoprost inside the anterior chamber. An ab-interno approach is used to visualize the anterior chamber angle. The scleral anchor is then implanted into the trabecular meshwork, and secure attachment is ensured by nudging the device.

Posted: 6/15/2020

Keywords:

Drug Delivery

Please log in to leave a comment.

More in Glaucoma

Angle-Based MIGS for a Patient With Severe Glaucoma

Angle-Based MIGS for a Patient With Severe Glaucoma

John P. Berdahl, MD; Tanner J. Ferguson, MD; and Mitch Ibach, OD, FAAO

When a Minimally Invasive Procedure Fails

When a Minimally Invasive Procedure Fails

Iqbal Ike K. Ahmed, MD, FRCSC; Arsham Sheybani, MD; and Rachel G. Simpson, MD

Innovations in Glaucoma: The FYSX OPAP Device

Innovations in Glaucoma: The FYSX OPAP Device

I. Paul Singh, MD; and John P. Berdahl, MD

Challenging Cases: From PRK to IOP

Challenging Cases: From PRK to IOP

Radhika Rampat, MBBS, BSc(Hons), FRCOphth, and Marguerite B. McDonald, MD, FACS